TickerFactsScreenerDevelopers

AEON Biopharma, Inc. (AEON) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$1.49M2022: -$35.58M2024: -$20.29M2025: -$17.31M-$17.31M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$17.31M+14.7%
2024-$20.29M—
2022-$35.58M-2280.5%
2021-$1.49M—